OPKO Health, Inc.
OPK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $713,142 | $863,495 | $1,004,196 | $1,774,718 |
| % Growth | -17.4% | -14% | -43.4% | – |
| Cost of Goods Sold | $402,109 | $545,368 | $715,977 | $1,193,194 |
| Gross Profit | $311,033 | $318,127 | $288,219 | $581,524 |
| % Margin | 43.6% | 36.8% | 28.7% | 32.8% |
| R&D Expenses | $105,214 | $89,593 | $73,887 | $76,850 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $304,220 | $300,559 | $372,672 | $468,857 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $53,664 | $84,996 | $67,913 | $17,067 |
| Operating Expenses | $463,098 | $475,148 | $514,472 | $562,774 |
| Operating Income | -$152,065 | -$157,021 | -$226,253 | $18,750 |
| % Margin | -21.3% | -18.2% | -22.5% | 1.1% |
| Other Income/Exp. Net | $141,703 | -$27,405 | -$165,651 | -$33,404 |
| Pre-Tax Income | -$10,362 | -$184,426 | -$391,904 | -$14,654 |
| Tax Expense | $42,844 | $4,437 | -$63,499 | $15,489 |
| Net Income | -$53,224 | -$188,863 | -$328,405 | -$30,143 |
| % Margin | -7.5% | -21.9% | -32.7% | -1.7% |
| EPS | -0.077 | -0.25 | -0.46 | -0.046 |
| % Growth | 69.3% | 45.7% | -911% | – |
| EPS Diluted | -0.077 | -0.25 | -0.46 | -0.046 |
| Weighted Avg Shares Out | 694,020 | 751,768 | 719,061 | 648,078 |
| Weighted Avg Shares Out Dil | 694,020 | 751,766 | 719,061 | 648,078 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8,426 | $3,983 | $1,981 | $28 |
| Interest Expense | $47,465 | $13,506 | $12,056 | $18,880 |
| Depreciation & Amortization | $98,176 | $105,297 | $108,655 | $78,716 |
| EBITDA | $135,279 | -$65,516 | -$270,810 | $83,571 |
| % Margin | 19% | -7.6% | -27% | 4.7% |